Breeze Meds vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Novi scores higher on our rubric, 7.8/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Breeze Meds - from $199/mo →or find your match

Novi beats Breeze Meds overall, scoring 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Novi is from $133/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.

A side-by-side look at Breeze Meds and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Breeze Meds

#29 of 54

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Higher Rated

Novi

#9 of 54

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Feature	Breeze Meds	Novi
Why each one	No subscription required, pay per order rather than committing to recurring billing, with three formulation options including oral tablets.	Combination of six named clinicians (most compounded-only platforms disclose zero or one), month-to-month billing with no commitment, and aggressive promotional pricing as low as $99/mo on the offer landing, a flexibility-and-headcount profile most direct competitors at this price tier do not match.
Our Score	7.3/10	7.8/10
Headline Price	from $199/mo	from $133/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want to order compounded GLP-1s month-by-month with no subscription commitment	Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out for	Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.	Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking	#29	#9
Get started	Visit Breeze Meds	Visit Novi

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required, order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
−Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
−Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.

Novi

Pros

+Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
+Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
+Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
+Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
+Free 2-day shipping; Novi markets compounded semaglutide and tirzepatide, which are not FDA-approved brands or generics and are not established as equivalent to Wegovy, Ozempic, Mounjaro, or Zepbound
+100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
−Founding year, headquarters city, and corporate ownership are not publicly disclosed
−Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
−Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

Novi edges out Breeze Meds with a score of 7.8/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Novi is from $133/mo.